DUBAI, United Arab Emirates;February 2025 - Throat cancer is one of the fastest-growing cancers, and it is often linked to ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with Keytruda for first-line treatment.

Head and neck cancer is diagnosed in at least 700,000 patients each year. A team of 27 doctors has found a comforting means ...

HPV infection is most commonly associated with cervical cancer, since roughly 99 per cent of all cervical cancer cases are connected to HPV. Nonetheless, experts warn that HPV is a virus that affects ...

Human Papillomavirus (HPV) is widely recognized as a cause of cervical cancer in women, but a concerning trend has emerged: ...

Cancer of the tonsil is a rare type of head and neck cancer. Cancer happens when abnormal cells start to divide and grow in an uncontrolled way. Symptoms often include a painless neck lump and a sore ...

Müller-Haus, E-826, Murtenstrasse 35, Bern 3008, Switzerland. E-mail: [email protected] Mol Cancer Ther 2025;24:214–29 Deceased. L. Hayrapetyan and S.M. Roth contributed equally and shared first ...

They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

Boston-based Bicara launched in 2021 and is a subsidiary of Indian pharma company Biocon, which provided its seed funding. Bicara is also studying ficerafusp alfa, its lead candidate, in anal cancer ...